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Abstract
Site-specific histone modifications are important epigenetic regulators of gene expression. As deregulation of genes often
results in complex disorders, corrective modulation of site-specific histone marks could be a powerful therapeutic or
disease-preventive strategy. However, such modulation by dietary compounds and the resulting impact on disease risk
remain relatively unexplored. Here we examined phenethylisothiocyanate (PEITC), a common dietary compound derived
from cruciferous vegetables with known chemopreventive properties under experimental conditions, as a possible
modulator of histone modifications in human colon cancer cells. The present study reports novel, dynamic, site-specific
chemical changes to histone H3 in a gene-promoter-specific manner, associated with PEITC exposure in human colon
tumor-derived SW480 epithelial cells. In addition, PEITC attenuated cell proliferation in a concentration- and time-
dependent manner, likely mediated by caspase-dependent apoptotic signalling. The effects of PEITC on histone
modifications and gene expression changes were achieved at low, non-cytotoxic concentrations, in contrast to the higher
concentrations necessary to halt cancer cell proliferation. Increased understanding of specific epigenetic alterations by
dietary compounds may provide improved chemopreventive strategies for reducing the healthcare burden of cancer and
other human diseases.
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Introduction
Cancer remains the second-leading cause of all deaths in the
United States [1]. Fortunately, many dietary compounds can
potently modulate various molecular targets, leading to prevention
of cancer initiation, promotion, and progression. In particular,
fruits and vegetables are rich sources of biologically active
compounds that often have low toxicities but significant efficacies
[2]. In the past, cancer was narrowly conceived as a disease of
mutations, but newer research also associates the diseased state
with the perturbation of cellular regulatory networks, and the
disruption of gene function and gene regulation are now both
recognized as hallmarks of cancer [3,4,5]. Hence, disease-
preventive measures aiming to target key elements of the networks
regulating gene function, such as chromatin, might be effective.
The alterations of site-specific chromatin modifications, known as
epigenetic changes, are relevant to clinical oncology, as they are
closely associated with gene expression and network perturbations
in the diseased state [6,7]. Therefore, elucidating the role of
dietary compounds in resetting the aberrant epigenetic landscapes
responsible for altered gene expression may facilitate preventive
medical practices.
The epigenetic basis of gene regulation is manifested at the
structural unit of chromatin, the nucleosome, which is an assembly
of histone octamers wrapped by genomic DNA. Modifications of
histones constitute a major molecular control point in the
regulation of gene expression, and these modifications are
frequently altered in cancers [6,7]. Among many known histone
amino acid tail modifications, methylation and acetylation of the
lysine residues on histone H3 have been extensively studied with
regard to gene silencing and gene regulation. Dimethylation of H3
at lysine 9 (H3K9me2) and trimethylation of H3 at lysine 27
(H3K27me3) are frequently associated with transcriptional
repression and gene silencing [8]. Site-specific histone lysine
methylations are catalyzed by histone methyl transferases (HMTs),
and the removal of methyl groups are catalyzed by demethylases.
Similarly, deacetylation of histones at gene promoters catalyzed by
histone deacetylases (HDACs) is correlated with the condensation
of chromosomal domains marking regions of transcriptional
incompetence and down-regulation of the associated genes [9].
Though in vitro studies of the role of dietary phytochemicals in
modulating the levels of HMTs and HDACs exist in small
numbers [10], the modulation of position-specific H3 lysine
modifications by dietary compounds in a gene-specific manner
remains relatively unexplored [11]. Here, we investigated H3-
acetylation (H3-Ac) and site-specific H3 lysine methylations
(H3K27me3 and H3K9me2) in association with phenethylisothio-
cyanate (PEITC)-mediated gene expression modulation in human
colon cancer cells. This is a follow up of our previous reports on
PEITC as a dietary compound with potential anti-inflammatory
functions in various experimental models [12,13].
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PEITC occurs naturally in the form of its glucosinolate
precursor, gluconasturtiin, in vegetables such as cabbage, cauli-
flower, wintercress, and broccoli. PEITC has shown potential
antioxidant and chemopreventive activity in experimental models
of various cancers [14,15]. It exhibited no apparent toxicity in
drug safety studies [16] and is currently in clinical trials for lung
cancer treatments (clinicaltrials.gov: NCT00005883,
NCT00691132). In mouse, we previously demonstrated that
PEITC attenuates colon inflammation and modulates a number
of potential biomarkers related to inflammation and colon
carcinogenesis. These biomarkers included genes related to the
inflammatory response, apoptosis, cell cycle regulation, prolifera-
tion, cytokine/chemokine activity, and transcriptional regulation
[12,13].
Colorectal cancer is the second-leading cause of cancer-related
deaths in the United States [21]. Interestingly, a mechanistic
association between chronic inflammation and an increased risk of
cancer arising from inflammation-induced genetic and epigenetic
instability is now well accepted [17]. Key players in this association
include transcription factors, such as nuclear factor kappa B
(NFkB) and signal transducers and activators of transcription
(STATs), cytokines/chemokines, and matrix metalloproteinases
(MMPs), a multigene family of zinc-dependent extracellular
matrix-remodeling endopeptidases. These cellular mediators,
some of which we studied previously in mouse models [12,13],
have important functions related to the bypassing of adaptive
immunity, proliferation, survival of malignant cells, tumor growth,
angiogenesis, invasion, and metastasis [17,18,19,20]. The current
study investigated chromatin changes in association with PEITC-
mediated modulation of the expression of these mediators in
human colon cancer cells.
Materials and Methods
Drug and Chemicals
Dimethyl sulfoxide (DMSO), lipopolysaccharide (LPS, from
Escherichia coli strain O55:B5), penicillin/streptomycin, and phe-
nethylisothiocyanate (PEITC) were purchased from Sigma-Aldrich
(St. Louis, MO). Dulbecco’s Modified Eagle’s Medium (DMEM),
fetal bovine serum (FBS), and TrypLE were purchased from Gibco
(Grand Island, NY). Human interferon-c (IFNc) was purchased
from R&D Systems (Minneapolis, MN). Phosphate-buffered saline
(PBS) was purchased from Thermo Scientific (Rockford, IL). For
western blotting, an antibody against b-actin was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA), and antibodies
against STAT1 and phosphorylated STAT1 (Ser727) were
purchased from Millipore (Billerica, MA). Dylight 800 anti-rabbit
secondary antibody was purchased from Li-Cor Biosciences
(Lincoln, NE). Antibodies used for the chromatin immunoprecip-
itation (ChIP) assay were anti-acetyl-Histone H3, anti-trimethyl-
Histone H3 (Lys27), and rabbit IgG for negative control samples
from Upstate Biotechnology (Billerica, MA) and anti-dimethyl-
Histone H3 (Lys9) from Abcam (Cambridge, MA). Enzymes used
for the ChIP assay were micrococcal nuclease (MNase) from Cell
Signaling (Beverly, MA) and Proteinase K from Thermo Scientific
Pierce (Rockford, IL). Oligonucleotides were synthesized by IDT
DNA Inc. (Coralville, IA). The ChIP assay chemicals aprotinin,
DL-1, 4-dithiothreitol (DTT), and Nonidet-P40 (NP-40) were
purchased from Thermo Scientific (Rockford, IL), while sodium
butyrate, protein-A sepharose, and sucrose were purchased from
Sigma-Aldrich (St. Louis, MO). ChIP incubation buffer was
purchased from Abcam (Cambridge, MA), and a DNA-purifying
slurry for ChIP-grade DNA purification was purchased from
Diagenode (Denville, NJ).
Cell Culture
SW480 (ATCC CCL-228), HT-29 (ATCC HTB-38), and
THP-1 (ATCC TIB-202) cell lines obtained from American Type
Culture Collection (Manassas, VA) were grown in DMEM
supplemented with 10% FBS, 1% penicillin (25 U/ml)/strepto-
mycin (25 mg/ml) in a 95% air/5% CO2-humidified atmosphere
at 37uC. Three cell lines were cultured as described [24]. Briefly,
THP-1 cells were treated with PEITC at a pre-determined dose
for 8 h before elicitation with LPS (1 mg/ml). SW480 and HT-29
cells were primed with IFNc (10 ng/ml) for 12 h, treated with
PEITC for 5 h, and then stimulated with LPS (10 or 50 ng/ml) for
4 or 1 h, respectively. LPS and PEITC were dissolved in DMEM
and DMSO, respectively, with DMSO used as vehicle. For every
experiment, one positive control (cells treated with DMSO and
LPS/IFNc) and one negative control (cells treated with DMSO
only) were included. Two replicates were made for each treatment.
PEITC treatments were performed at 2.5, 5, 10, and 15 mM
concentrations. For analyzing the time-dependent expression
changes of STAT1 and other genes of interest (GoI) in response
to PEITC, SW480 cells were treated with 10 mM PEITC for 5, 8,
12, and 18 h. All experiments were repeated a minimum of three
times.
Cell Viability Assay, Dose Range Determination, and Cell
Proliferation
A CellTiter 96 AQueous One Solution Cell Proliferation
Assay kit (MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethox-
yphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; Promega,
Madison, WI) was used to determine the relative number of
viable SW480 cells remaining after PEITC treatment, according
to the manufacturer’s instructions. The assay was performed by
treating SW480 cells with different PEITC concentrations,
followed by adding 20 ml CellTiter reagent directly to culture
wells, incubating for 2 h at 37uC, and then recording the
absorbance at 490 nm with a BioTek Synergy H4 plate reader
(BioTek, Winooski, VT). Background 490 nm absorbance was
corrected by preparing a triplicate set of control wells (without
cells) containing the same volumes of culture medium and
CellTiter reagent as in the experimental wells. The same assay
was also carried out using higher concentrations of PEITC (up
to 80 mM) and exposing cells for longer time periods of up to
48 h to determine the anti-proliferation effects of PEITC in
SW480 cells (Figure 1). It should be noted that even lower
concentrations (above 5 mM) of PEITC treatment for longer
incubation periods such as 48 h induce significant cell death
and mRNA degradation (Figure 1). Concentrations of PEITC at
which no significant loss of cell viability occurred (no cytotoxic
effects) were selected for all further experiments (Figures 2, 3, 4,
5, 6). Hence, all gene expression assays (RNA and protein
expression) and epigenetic changes reported in this manuscript
were determined at the 5 h time point unless otherwise
mentioned. A 40 mM exposure of PEITC for 12 h or less did
not show a statistically significant loss in cell viability (Figure 1A).
For time-dependent observations (Figure 5 and S1, S2, S3, S4,
S5), cells with 10 mM PEITC treatment were incubated for up
to 18 h, as a statistically significant loss in cell viability was not
observed until that time point (Figure 1A).
DNA Fragmentation Assay for Detection of Apoptosis
SW480 cells treated with different concentrations of PEITC
were incubated for 48 h before harvesting genomic DNA using
DNAzol (Invitrogen, Grand Island, NY), following the manufac-
turer’s protocol. DNA fragmentation was visualized using 1.5%
Epigenetic Modifications by PEITC
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agarose gel electrophoresis and GelRed staining (Biotium,
Hayward, CA).
Total RNA Extraction, Purification, and cDNA Synthesis
Total RNA was extracted from cells using TRIzol reagent
(Invitrogen, Grand Island, NY), following the manufacturer’s
instructions. RNA was quantified by absorption measurements at
260 and 280 nm using the NanoDrop spectrophotometer system
(NanoDrop Technologies, Wilmington, DE). RNA was then
treated with DNase I (Invitrogen Inc.), following the manufactur-
er’s guidelines to remove any traces of DNA contamination. The
cDNAs were synthesized using 3 mg of RNA for each sample using
the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA), following the manufacturer’s
protocol. RNA extraction, purification, and cDNA synthesis were
performed as previously described [13].
Real-Time Quantitative PCR
The synthesized cDNAs were diluted four-fold. Two microliters
of each diluted sample was added to 0.5 ml of gene-specific primers
and 12.5 ml of Power SYBR Green PCR master mix (Applied
Biosciences, Foster City, CA) and the final volume brought to
25 ml by adding sterile distilled water. PCR amplifications were
performed on a MX3005P system (Roche/Stratagene) using one
cycle at 50uC for 2 min, one cycle of 95uC for 10 min, 40 cycles of
15 s at 95uC and 1 min at 60uC, and a last cycle with 95uC for
1 min, 55uC for 30 s, and 95uC for 30 s, as described [13]. NTC
(no template control), no-RT control, and PEITC-only controls
were utilized as appropriate for quality control purposes. All
samples were run in duplicate. Gene-specific, intron-spanning
primers used in the current study are described in Table 1 (for
PEITC concentration-dependent mRNA expression) and Table 2
(for ChIP experiments). Calculations of relative expression levels
were performed using the DDCt-method [25]. Data values are
averages of at least three independent experiments and are
expressed as the relative mRNA quantity with respect to a positive
control, which is normalized to a value of 1.0.
Western Blot Analysis
For immunoblot analyses, IFNc-primed, PEITC-treated
SW480 cells were activated with LPS for 4 h and harvested using
RIPA lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl,
1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium
deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM b-glycero-
phosphate, 1 mM Na3VO4, 1 mg/ml leupeptin). For nuclear
extract preparation and protein concentration determination, the
manufacturer’s (Thermo Scientific, Rockford, IL) protocols for
NE-PER Nuclear Extraction Reagents and the Pierce BCA
Protein Assay kit were followed. Proteins (50 mg/lane) were
separated by 12% SDS-PAGE and the products were electro-
transferred to polyvinyldene difluoride (PVDF) membranes
(Thermo Scientific, Rockford, IL). The membranes were blocked
with 5% skim milk for 1 h, washed three times in PBS, incubated
with primary antibody (rabbit anti-b-actin from Santa Cruz
Biotechnology and rabbit anti-STAT1 and anti-phosphorylated
STAT1 [Ser727] from Millipore) overnight, washed three times in
Tween-20 (0.1% in PBS), and incubated with Dylight 800 anti-
rabbit secondary antibody from Li-Cor for 1 h, all at room
temperature. After rinsing in Tween-20 (0.1% in PBS), blots were
imaged with an Odyssey infrared imaging system (Li-Cor).
Quantitative Chromatin Immunoprecipitation (ChIP)
Analysis
Cells were plated at a density of ,3–56106 per well in 6-well
plates 18–24 h before treatment, then rinsed twice with cold PBS
and harvested after treatment [26]. The ChIP assay was
performed using a modified version of a previously published
method [27]. Cells were suspended in ice-cold Buffer 1 (0.06 M
KCL, 15 mM NaCl, 5 mM MgCl2, 15 mM Tris-HCl pH 7.4–
7.6, 0.1 mM EGTA, 0.3 M sucrose, 180 mg aprotinin, 5 mM
sodium butyrate, 0.1 mM PMSF, 0.5 mM DTT) and Buffer 2
(0.8% NP40+ Buffer 1) for 10 min on ice. Cell suspensions were
added to new tubes containing Buffer 3 (0.06 M KCL, 15 mM
NaCl, 5 mM MgCl2, 15 mM Tris-HCl pH 7.4–7.6, 0.1 mM
EGTA, 1.2 M sucrose, 180 mg aprotinin, 5 mM sodium butyrate,
0.1 mM PMSF, 0.5 mM DTT). After the samples were centri-
fuged, the nuclei were collected and re-suspended in MNase
Figure 1. Time- and concentration-dependent effects of PEITC on SW480 cell proliferation. Following 12, 24, and 48 h PEITC exposure
and a subsequent 2 h incubation with CellTiter aqueous reagent (Promega), A490 nm was measured in SW480 cells in a BioTek Synergy H4 reader.
Percentage cell viability is shown relative to control (no PEITC) as the mean 6 SEM (A); Concentration-dependent effects of PEITC at 48 h on DNA
fragmentation (B); Concentration-dependent modulation of the expression of genes related to apoptosis and the cell cycle by PEITC at 48 h. GAPDH
was used as a housekeeping control for relative quantification of gene expression changes (C); for all experiments n = 3. *p,0.05, **p,0.01,
***p,0.001. No loss in cell viability in the 10 mM PEITC group compared with the no-PEITC group was observed up to 12 h.
doi:10.1371/journal.pone.0064535.g001
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digestion buffer (0.32 M sucrose, 50 mM Tris-HCl pH 7.4–7.6,
4 mM MgCl2, 1 mM CaCl2, 0.1 mM PMSF, 5 mM sodium
butyrate), incubated in a 37uC water-bath for 6 min, and 20 ml of
0.5 M EGTA added to stop the reaction. In this way, chromatin
was digested to an average DNA length of 300–800 bp. After
centrifugation, the supernatant contained the first soluble fraction
of chromatin, S1. The pellet was re-suspended in dialysis buffer
(1 mM Tris-HCl pH 7.4–7.6, 0.2 mM EDTA, 0.2 mM PMSF,
5 mM sodium butyrate), placed on ice for 1–2 h, and centrifuged.
The resulting pellet was the second soluble chromatin fraction, S2.
Aliquots of the two chromatin fractions (10–20 mg S1 and 10–
20 mg S2) were mixed, the volume diluted to 1 ml with ChIP
incubation buffer (Abcam), and the mixture subjected to
immunoprecipitation with specific antibodies, with rotation
overnight at 4uC. Immunoprecipitated chromatins were extracted
by using protein-A sepharose and purified by using a DNA-
purifying slurry (Diagenode, Denville, NJ). An aliquot of each
immunoprecipitated DNA template (100–150 ng) was used for
quantitative real-time PCR analysis using sequence-specific gene
promoter primers (Table 2). The PCR-amplified immunoprecip-
itated DNA signal was normalized to the PCR signal from non-
immunoprecipitated input DNA [28]. The signals obtained by
precipitation with control IgG were subtracted from the signals
obtained with the specific antibodies. Calculations were based on
the average of at least three independent experiments, and the
results are expressed as a percentage of the input (Figures 3, 4, 5,
S1, S2, S3, S4, S5).
Statistical Analysis
The statistical significance of treatment groups was assessed by
one-way ANOVA followed by Dunnett’s posthoc analysis for
comparison of individual treatment group with the control. Data
are expressed as means 6 SEM. All experiments were repeated at
least three times. A probability (p) value of 0.05 or less was
considered to be the criterion for a significant difference.
Results
Effect of PEITC on Gene Expression in Human Cells
To reexamine the gene expression results in response to PEITC
treatments obtained in our previous study of mouse macrophages
[12], we carried out assay optimizations using three human cell
Figure 2. PEITC concentration-dependent mRNA expression of genes of interest (GoI) in SW480 cells at 5 h of PEITC exposure. Six
genes are shown for which PEITC-associated changes in H3 modifications were also observed. GoIs for which PEITC-exposure-associated H3 changes
were not observed are shown in Table 3, but not in the current figure. The effects of PEITC treatments were measured by the relative mRNA quantity
expressed by GoI in the treated cells. The mRNA quantity was measured using real-time RT-PCR, with GAPDH as an internal control. Lower values
represent greater inhibitory effects. Values are mean 6 SEM (n = 6). *p,0.05, **p,0.01, ***p,0.001. When all values below the dotted line
correspond to the same category of p value, individual stars are omitted to avoid overcrowding of the figure. Statistical significances were measured
relative to the positive control, which are cells treated with LPS and no PEITC, showing the highest gene induction levels.
doi:10.1371/journal.pone.0064535.g002
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lines: the human monocytic cell line THP-1 and the human colon
epithelial cell lines HT-29 and SW480. Optimization included
induction parameters of the inflammatory response in cells treated
with LPS or LPS+IFNc and the range of non-cytotoxic PEITC
concentrations and exposure durations. Information did not exist
in the literature about PEITC effects in SW480 and THP-1 cells.
In the previous study [12], 21 LPS-induced genes were suppressed
three-fold or more by 10 mM PEO (PEITC Essential Oil)
compared with LPS activation alone in RAW 264.7 mouse
macrophage cells. (PEO is PEITC obtained from Barbarea verna
seeds [15]. Both PEO and commercially purchased PEITC are
composed of .95% pure PEITC. In the current study with THP-
1, HT-29, and SW480 cells, we included two additional genes,
MMP7 and MMP9, for a total of 23 final genes of interest (GoI).
PEITC suppressed 9, 3, and 13 out of the 23 genes in THP-1, HT-
29, and SW480 cells, respectively (Table 3). The results also
showed that SW480 cells were the most responsive to IFNc-
primed LPS induction among the three cell lines tested. The 13
genes down-regulated by PEITC treatment in SW480 cells
represent key cellular players in inflammation and cancer.
Therefore, all subsequent gene expression experiments were
carried out using these 13 genes in SW480 cells. The 10 genes
that were screened but were not induced/expressed in the human
cell lines are not discussed further in this manuscript. Subsequent
to gene expression analyses, changes in histone modifications
(H3K27me3, H3K9me2, and H3-Ac) in the promoter regions of
each of these 13 genes were investigated. We observed differential
H3-modifications relative to controls for only six out of these 13
genes, which are discussed in detail in the manuscript. All 13
genes, whether or not H3 modifications were observed in their
promoter regions in association with PEITC exposure, are listed in
Table 3.
Effect of PEITC on Colon Cancer (SW480) Cell
Proliferation
Several of the selected genes observed to be modulated by
PEITC in SW480 cells regulate cell proliferation during carcino-
genesis (Table 3). Therefore, we investigated whether PEITC had
an antagonistic effect on tumor cell proliferation, finding that
PEITC attenuated viability in SW480 cells in a time- and
concentration-dependent manner (Figure 1A). Interestingly, the
PEITC concentrations and exposure times necessary to halt
cancer cell multiplication are higher and longer, respectively, than
those necessary to induce changes in chromatin chemistry
(Figures 3, 4, 5, S1, S2, S3, S4, S5) and gene expression
(Figures 2, 6, S1, S2, S3, S4, S5). For concentrations below
80 mM, at least a 24 h exposure was necessary to significantly
induce cancer cell death (Figure 1). For most of the remaining
experiments (Figures 2, 3, 4, and 6), we used a PEITC exposure of
5 h at or below 15 mM. In Figures 5 and S1, S2, S3, S4, S5,
Figure 3. Histone H3 methylation changes at the promoter regions of genes of interest (GoI) in SW480 cells. Chromatin from SW480
cells was harvested after 5 h of 10-mM PEITC treatment. The results of ChIP analyses using (A) anti-trimethyl-Histone H3 Lys27 (H3K27me3) and (B)
anti-dimethyl-Histone H3 Lys9 (H3K9me2) antibodies are shown. Out of 13 GoIs tested in SW480 cells, six genes showed statistically significant PEITC-
associated changes in H3K27me3 states and one gene showed statistically significant PEITC-associated changes in H3K9me2 state. DNA sequences
were quantified by real-time PCR using promoter primers. Average percentage input 6 SEM (n= 3) from each experiment is plotted. *p,0.05,
**p,0.01, ***p,0.001 compared with positive-control cells.
doi:10.1371/journal.pone.0064535.g003
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10 mM PEITC was used at various time points in SW480 cells for
up to 18 h of PEITC exposure time. A 10 mM concentration of
PEITC significantly affected cell viability at or beyond 24 h
(Figure 1A), and a DNA fragmentation assay (Figure 1B) revealed
that the antiproliferative effects of PEITC may be due to apoptotic
up-regulation as also evidenced by higher expression of caspase 3
and 8 (Figure 1C). The absence of significant changes in the cell
cycle protein CyclinD1 (CCND1) indicates that PEITC does not
directly inhibit the cell cycle (Figure 1C).
Modulation of Chemokines by PEITC in Human Colon
Cells
Chemokines play a major role in the maintenance of
inflammatory processes in the large bowel. The production of
chemokines within the intestine establishes a chemotactic gradient
capable of increasing the migration of monocytes/macrophages,
granulocytes, and lymphocytes from the bloodstream through the
endothelium into both the mucosa and submucosa during chronic
inflammatory bowel diseases (IBD) [29]. Previously, we observed
that PEITC reduced inflammation, depletion of goblet cells, and
infiltration of inflammatory cells in mouse mucosa and submucosa
[12]. In the current study, concentration-dependent PEITC-
mediated attenuation of mRNA levels of four proinflammatory
chemokines/cytokines (CCL2, CSF2, CXCL10, and IL8) was
observed in SW480 cells (Table 3, Figure 2). Individual ChIP
experiments on these chemokine promoters revealed hyper-
trimethylation of H3 at lysine 27 (increased H3K27me3 states)
surrounding the promoter regions of IL8 and CCL2 and an
additional decreased acetylation surrounding the promoter regions
of IL8 associated with 10 mM PEITC exposure (Tables 3–4,
Figures 3A and 4). However, a time-dependent inverse correlation
was observed for H3K27me3 (repressive mark) but not H3-Ac
with IL8 mRNA expression levels (Table 4, Figure S5). In the case
of CCL2, mRNA levels and H3K27me3 states were observed to
vary together, ruling out a potential causal relationship (Table 4,
Figure S4). Although polycomb repressive complex 2 (PRC2)-
catalyzing H3K27 trimethylation is involved in cytokine gene
reprogramming in response to inflammatory stimuli [30,31], the
apparent selectivity of PEITC in the context of histone modifica-
tions surrounding the promoter regions of the targeted chemo-
kines/cytokines leads us to believe that PEITC is unlikely to
directly affect the PRC2.
PEITC Exposure Perturbs Transcription Factor Activities in
Human Colon Cells
The NFkBs and STATs are two important families of
transcription factors activated in response to a variety of stimuli
to regulate multiple cellular processes, including the immune
response and carcinogenesis. The NFkBs and STATs have distinct
as well as synergistic effects on downstream effector gene induction
[32]. The role of NFkB in IBD [33] as well as the effect of PEITC
on NFkB activity [34,35,36,37] are well studied. Here we observed
Figure 4. Histone H3 acetylation changes at the promoter region of genes of interest (GoI) in SW480 cells. Chromatin from SW480 cells
was harvested after 5 h of 10 mM PEITC treatment. Out of 13 GoIs tested in SW480 cells, two genes showed statistically significant PEITC-associated
changes in H3-Ac status. The results of ChIP analyses using an anti-acetyl-Histone H3 antibody are shown. DNA sequences were quantified by real-
time PCR using promoter primers. Average percentage input 6 SEM (n= 3) from each experiment is plotted. *p,0.05, ***p,0.001 compared with
positive-control cells.
doi:10.1371/journal.pone.0064535.g004
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PEITC-mediated down- regulation of various NFkB family
members, namely NFkB1, NFkBia, and REL proteins, which
was not previously reported for SW480 cells (Table 3, Figure 2).
Intriguingly, a time-dependent increase in the H3K27me3 state
was associated with a time-dependent decrease in NFkB1
expression in PEITC-exposed cells, suggesting potential epigenetic
regulation of NFkB1 that merits future validation (Table 4,
Figures 3A, S1). Additionally, STAT proteins are dormant
cytoplasmic transcription factors that become activated after
phosphorylation by kinases in response to various stimuli,
including cytokines, growth factors, and LPS [32]. The activated
proteins migrate into the nucleus and bind to specific promoter
elements to regulate gene expression [38]. An increase in STAT1
expression and activation in human ulcerative colitis (UC) was
reported [22], and UC patients are at higher risk of colon cancer
[22]. We had earlier reported a novel PEITC-mediated attenu-
ation of activated STAT1 in mouse cells [12]. Here we observed a
PEITC-mediated down-regulation of STAT1 mRNA in all three
human cell lines (Table 3, Figures 2, 5). Changes in STAT1
mRNA expression also correlated with time-dependent changes in
H3K27me3 levels surrounding the promoter region of STAT1 in
SW480 cells (Figures 3A and 5). Since STAT1 is a transcription
factor with the potential to regulate numerous downstream
effector genes and since, until now, the relationship between
STAT1 expression and activation in response to PEITC exposure
has been relatively unexplored (aside from our own observations),
we delved deeper into the nature of this relationship. The activated
form of STAT1 (phosphorylated at Serine 727) was not detected at
all in the nuclear extracts (Figure 6) until after activation with LPS
in IFNc-primed SW480 cells. Once activated, an increase in
STAT1 and pSTAT1 proteins was observed (Figure 6), both of
which were attenuated by PEITC in a concentration-dependent
manner. In our mRNA detection experiments, the levels of
STAT1 were lowered by PEITC in both a time- (Figure 5) and
concentration-dependent (Figure 2) manner that was inversely
correlated (inset, Figure 5) with H3K27me3 levels (Figures 3A and
5). However, even after an 18 h exposure to 10 mM PEITC, the
levels of STAT1 mRNA did not revert to unstimulated levels
(Figure 5). Also, changes in H3K9me2 or acetylation levels
surrounding the STAT1 promoter were not observed in response
to PEITC treatments (Table 4), indicating that the effects of
PEITC on chromatin chemistry are likely directed in a highly gene
promoter-specific manner.
Effect of PEITC on MMPs in Human Cancer Cells
MMPs are considered to be the predominant proteases in the
pathogenesis of mucosal ulcerations associated with IBD. MMP7
expression in inflammatory and endothelial cells suggests that it
has a role in both colitis-associated neoangiogenesis and inflam-
matory changes [39]. In many malignancies, including colorectal
cancers, MMP7 and MMP9 are overexpressed and play a role in
cancer progression by enhancing metastatic potential and tumor
invasion [40,41]. While induction of both MMP7 and MMP9
were reduced by PEITC, possible epigenetic control of such
repression was only observed for MMP7 (Table 3). The promoter
of MMP7 showed H3 hypermethylation at lysine 27 and
hypoacetylation of H3 in PEITC-treated cells compared with
cells not exposed to PEITC (Figures 3A, 4). Interestingly, time
dependent correlation of H3 modification and MMP7 expression
was only observed for H3-Ac state (activation mark, hence,
directly correlated) and not for the H3K27me3 state (Table 4,
Figure S2). In our previous report, we did not test the effects of
PEITC treatment on either of the MMP genes. However given
their key role in the pathogenesis of IBD and in development of
colon cancer, we included these two genes in our current
investigation. To our knowledge, mRNA attenuation of MMP7
by PEITC as well as PEITC-exposure-associated changes in
chromatin decorations on the MMP7 promoter have not been
reported previously.
Discussion
Epigenetic changes, although can be heritable, are potentially
reversible and may affect genomic stability and gene expression. In
recent years, great strides have been made in understanding the
epigenetic mechanisms that determine which genes can be turned
on and off and the implications for human health and disease.
Importantly, we now know that dietary factors and specific
Figure 5. Representative results showing the time-dependent
effects of 10 mM PEITC treatment on STAT1 mRNA levels and
on the H3K27me3 methylation state. SW480 cells were treated
with 10 mM PEITC at the indicated time points (A, B). The STAT1 mRNA
levels were normalized to GAPDH levels and expressed as a percentage
relative to positive-control cells (A). Histone H3 methylation changes at
the STAT1 promoter region in SW480 cells were determined using an
anti-H3K27me3 antibody for ChIP. DNA sequences were quantified by
real-time PCR (B). Data points represent the mean 6 SEM (n= 4) from
each experiment. *p,0.05, **p,0.01, ***p,0.001 compared with
positive-control cells. The green dotted lines indicate a possible inverse
correlation (for repressive marks) between changes in mRNA levels and
H3 modification status in the cells. The presence or absence of similar
correlations for the remaining five GoI are shown in Figures S1, S2, S3,
S4, S5.
doi:10.1371/journal.pone.0064535.g005
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nutrients can modulate epigenetic signatures (decorations) and,
therefore, susceptibility to disease [42]. Targeting the epigenome,
including the use of HDAC and DNA methyltransferase (DNMT)
inhibitors, is an evolving strategy for cancer chemoprevention and
has shown promise in cancer clinical trials [43]. However, it is not
known whether such a broad targeting strategy against the cancer
epigenome (in cancer cells) also has pleiotropic effects on cellular
pathways in normal cells. Here we present novel PEITC-exposure-
associated, potentially selective site- and promoter-specific regu-
lation of epigenetic events in cancer cells that may further validate
the health-protective utility of this chemopreventive/chemother-
apeutic agent.
PEITC and other isothiocyanates are capable of inhibiting the
development of cancer in experimental models through multiple
pathways, including, but not limited to, induction of carcinogen-
detoxifying phase 2 enzymes, induction of apoptosis, and
inhibition of cell cycle progression [44]. Previously, we had
reported that orally administered PEITC is pharmacologically
active in remitting acute and chronic bowel inflammation in
mouse UC models [12]. The biological activity of PEITC is
related to the inhibition of proinflammatory cytokines produced in
the inflamed gut. We subsequently elucidated potential novel
biomarkers associated with PEITC exposure in mouse macro-
phage cells [12]. We observed that 21 genes with cellular functions
related to inflammation, apoptosis, cell cycle regulation, prolifer-
ation, chemokine activity, and transcriptional regulation were
modulated in response to PEITC treatment [12]. Since persistent
inflammation in the colon is a major risk factor for the
development of colon carcinogenesis, we subsequently hypothe-
sized that the ability of PEITC to ameliorate the functions of
inflammatory and cell death mediators could be responsible for its
previously observed chemoprotective role in the colon [23]. The
current study reports that PEITC attenuates the proliferation of
human colon cancer cells (SW480) in a concentration- and time-
dependent manner (Figure 1A), likely mediated by a caspase-
dependent apoptotic pathway. Concentration- dependent up-
regulation of an initiator caspase (caspase 8) followed by an
effector caspase (caspase 3, Figure 1C), which corresponds to DNA
fragmentation in the cells (Figure 1B), in response to PEITC was
significant, given the key role of caspases in apoptosis [45]. We also
demonstrate novel and dynamic H3-site-specific chemical changes
associated with PEITC-exposure in the promoters of the GoIs
Figure 6. Immunoblot analyses showing suppression of total cellular STAT1 as well as activated nuclear pSTAT1 in response to
PEITC treatments in SW480 cells in a concentration-dependent manner. (A) Immunoblot. (B) Densitometric analyses of immunoblot. Cells
were pre-treated with various concentrations of PEITC for 5 h prior to 4 h LPS activation. Unstimulated cells and stimulated cells served as negative
and positive controls. Band intensities were normalized to b-actin. Values are expressed as means 6 SEM (n= 3) of three separate experiments.
*p,0.05, **p,0.01.
doi:10.1371/journal.pone.0064535.g006
Table 1. Primer sequences used for gene expression analyses.
Gene (accession number) Forward Reverse
GAPDH (NM_ 001256799.1) 59-agccacatcgctcagacac-39 59-gcccaatacgaccaaatcc-39
CASP3 (NM_004346.3) 59-ctggttttcggtgggtgt-39 59-ccactgagttttcagtgttctcc-39
CASP8 (NM_001080124.1) 59-ggtcacttgaaccttgggaat-39 59-tttctgctgaagtccatcttttt-39
CCND1 (NM_053056.2) 59-gaagatcgtcgccacctg-39 59-gacctcctcctcgcacttct-39
CD40 (NM_001250.4) 59-ggtctcacctcgctatggtt-39 59-cagtgggtggttctggatg-39
CCL2 (NM_002982.3) 59-agtctctgccgcccttct-39 59-gtgactggggcattgattg-39
IL8 (NM_000584.2) 59-agacagcagagcacacaagc-39 59-atggttccttccggtggt-39
MMP7 (NM_002423.3) 59-ctgacatcatgattggctttg-39 59-atctcctccgagacctgtcc-39
NFkB1 (NM_003998.2) 59-accctgaccttgcctatttg-39 59-agctctttttcccgatctcc-39
STAT1 (NM_007315.3) 59-tgagttgatttctgtgtctgaagtt-39 59-acacctcgtcaaactcctcag-39
Primers are shown for genes that are discussed in the paper beyond cell-screening experiments.
doi:10.1371/journal.pone.0064535.t001
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(Figures 3, 4, 5, S1, S2, S3, S4, S5, Table 3), whose expression
levels were also suppressed in the presence of PEITC (Figure 2, 6).
The changes in H3 decorations are observed to be gene-specific,
that is, a potential correlation between changes in histone
modification and mRNA expression over time was not uniform
across the GoIs in SW480 cells (Table 4, Figures 5, S1, S2, S3, S4,
S5). To the best of our knowledge, the biological effects of PEITC
have not been previously reported in SW480 cells.
In the current study, we focused our investigation on three very
well-characterized histone modifications. Site-specific alteration of
chromatin is a key signalling event in dynamic regulation and
maintenance of the genome. Recent high-resolution profiling of
histone methylation in the human genome showed increased
H3K9me2 and H3K27me3 levels at the transcriptional start sites
of silent/repressed genes compared with active genes
[46,47,48,49,50]. A third histone mark that is directly correlated
with gene expression is lysine acetylation (H3-Ac) [51,52].
Deacetylation of sites on each of the H3, H4, and H2B histones
are all associated with chromatin condensation and subsequent
gene repression. For convenience, we chose the anti-acetyl-H3
antibody to keep our analysis specific to histone H3.
Altogether, we examined the effects of PEITC on 23 genes in
three human cell lines representing the monocytic lineage (THP-1)
as well as colon cancer-derived epithelial cell types (HT-29 and
SW480, Table 3, Figure 2). Ten out of the 23 genes that were
modulated in mouse macrophage cells [12] did not induce/express
in response to LPS treatments in the human cell lines. Cell line-
specific variation in LPS responsiveness in vitro is not uncommon
in the scientific literature. Therefore, only results for the 13 genes
are shown in Table 3. Out of the three cell types tested, the
SW480 cells were most responsive to LPS-induction and PEITC-
mediated suppression of target genes (Table 3). Since a funda-
mental association between histone modification levels and tumor
aggressiveness has recently been proposed [7], three repressive
histone marks (H3K27me3, H3K9me2, and H3-deactylation)
were subsequently investigated in each of the 13 genes that were
down-regulated by PEITC in SW480 cells (Table 3). Out of these
13 genes (Table 3) that were investigated for PEITC-exposure-
associated changes in H3 decorations, only six (Figure 2, Table 4)
showed significant changes at 10 mM PEITC exposure for 5 h.
Three of these six genes had more than one type of change
Table 2. Primer sequences used for ChIP experiments.
Gene Forward Reverse
p-IL8 59-cagagacagcagagcacac-39 59-acggccagcttggaagtc-39
p-STAT1 59-gctggtcgtcactctcacaa-39 59-gaaagggcctacctacctcatt-
39
p-CD40 59-gaggggaaaaccgtgagg-39 59-gcgaccggagagagatcc-39
p-CCL2 59-gtggtcagtctgggcttaatg-39 59-ctgctgagaccaaatgagca-39
p-MMP7 59-cacacagcagcatttccatc-39 59-tcctgtggttctccatacagg-39
p-NFkB1 59-ttggcaaaccccaaagag-39 59-ggtttcccacgatcgattt-39
doi:10.1371/journal.pone.0064535.t002
Table 3. Genes down-regulated ($3-fold vs LPS activation alone) by PEITC in various human cells.
Gene
symbol Gene name
Partial Gene Ontology term
(www.geneontology.org)
Responsive
cell lines
% change in ‘‘S’’
to 10 mM PEITC
H3 changes in
PEITC- treated ‘‘S’’*
CCL2 Chemokine (C-C motif) ligand 2 Inflammatory response; Chemokine activity S/T 82.43 H3K27me3
CD40 CD40 antigen Signal transduction; Immune response;
Apoptosis
S/T 49.52 H3K27me3, H3K9me2
CSF2 Colony stimulating factor 2
(granulocyte -macrophage)
Immune response; Cytokine and
chemokine- mediated signaling pathway
S 36.55 NT
CXCL10 Chemokine (C-X-C motif) ligand 10 Inflammatory response; Chemokine activity S/H/T 91.63 ND
IL8 Interleukin 8 Immune response; Cytokine activity S/H 82.43 H3K27me3, H3Ac
MMP71 Matrix metalloproteinase 7 Zinc-dependent endopeptidases S 36.87 H3K27me3, H3Ac
MMP9 Matrix metalloproteinase 9 Zinc-dependent endopeptidases S/T 84.50 ND
NFkB1 Nuclear factor of kappa light chain gene
enhancer in B-cells 1, p105
DNA binding; Regulation of transcription S/T 41.98 H3K27me3
NFkBia Nuclear factor of kappa light chain gene
enhancer in B-cells inhibitor, alpha
Nucleus; Protein binding; Cytoplasm;
Regulation of cell proliferation;
Protein-nucleus import, translocation
S/T 38.44 NT
REL Reticuloendotheliosis oncogene DNA binding; Regulation of transcription S 28.80 ND
RELb Avian reticuloendotheliosis viral (v-rel)
oncogene related B
Transcription factor activity; Intracellular;
T-helper 1 type immune reponse
S/T 66.8 ND
STAT1 Signal transducer and activator
of transcription 1
DNA binding; Regulation of transcription S/H/T 11.28 H3K27me3
TNFaip3 Tumor necrosis factor, alpha-induced
protein3
Apoptosis; Zinc ion binding S/T 58.05 NT
Cell lines SW480, S; HT-29, H; THP-1, T.
All except MMP7 and MMP9 genes were tested in RAW macrophages in our previous report; Genes that were responsive in RAW cells but did not express/induce in any
of the human cell lines are not listed here, but were previously reported as potential targets of PEITC (Dey et al., 2010).
1Novel PEITC-mediated effect observed in the current study.
NT: Not Tested for H3 modification due to unsuccessful design of promoter primer.
ND: Tested, but none of the three H3 modifications were observed.
*Information based on 5 h incubation with PEITC in SW480 cells.
doi:10.1371/journal.pone.0064535.t003
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(Figures 2, 3, 4). All of these six genes (STAT1, NFkB1, MMP7,
CD40, CCL2, and IL8) were further examined for time-
dependent correlation of H3 modification states with mRNA
levels (Table 4). The correlation for STAT1 is shown in the main
text as a representative gene (Figure 5), while the remaining five
are presented as supplementary results (Figures S1, S2, S3, S4, S5).
Interestingly, an apparent time-dependent causal relationship was
selectively observed for four of the six genes (Table 4, Figures 5,
S1, S2, S5, correlation shown with green dotted lines; correlation
can be direct or inverse depending on activation or repressive
mark). H3K27me3 (repressive mark) states were inversely corre-
lated with STAT1, NFkB1, and IL8, and H3-Ac (activation mark)
levels were positively correlated with MMP7. For CD40 and
CCL2, such correlations were not observed (the absence of
correlation is shown with red dotted lines, Figures S3, S4).
Presence as well as absence of correlation between gene expression
and histone modifications indicates a possible selective gene-
specific function of PEITC. A number of possible scenarios that
might contribute to this are discussed below.
Three distinct classes of protein factors are responsible for the
maintenance and interpretation of the post-translational modifi-
cation (PTM) marks of the chromatin machinery that determine
the epigenetic landscape of the cell. These are writers (enzymes
adding marks), readers (protein modules binding to histone marks),
and erasers (enzymes removing/editing marks). In human, writers
catalyzing histone lysine methylations are site-specific HMTs (one
for H3K27 and around six for H3K9), while the methyl-removing
erasers are site-specific demethylases (three for each of H3K9 and
H3K27). Similarly, writers and erasers of acetylation marks are
site-specific histone acetyl transferases (HATs, around eight of
which are known to date) and HDACs (about eleven known),
respectively. In the context of gene suppression, gene-activating
chromatin marks (e.g., H3-Ac) are expected to decrease while
repressive marks (e.g., H3K27me3 and H3K9me2) are expected to
increase at gene promoters.
The apparent selectivity of PEITC-exposure-associated, time-
dependent H3K27me3 modifications surrounding the promoter
regions of the GoIs (inverse correlation for STAT1, NFkB1, and
IL8 with no correlation for CD40, CCL2, and MMP7) leads us to
believe that PEITC may not directly affect EZH2 protein (writer),
the HMT component of the PRC2 in SW480 cells. PEITC likely
promotes protein–protein interactions such that the PRC2
complex (or other enzyme complexes) may be recruited in the
vicinity of promoter-specific, DNA-binding transcription factors.
Conversely, it is also possible that PEITC disrupts protein–protein
interactions such that the demethylases are preferentially excluded
in the vicinity of the promoter-specific, DNA-binding transcription
factors, leading to changes in methyl marks. It is also possible that
a certain type of change, potentially resulting from PEITC
exposure, only occurs for genes with consensus sequences or
transcription factor binding commonality within their promoters.
These preferential writer/eraser localization possibilities will be
explored in future and reported elsewhere. Additionally, expres-
sion levels of the writer/eraser enzymes may also influence enzyme
localizations, and such a possibility is currently being examined.
Hence, when a time-dependent correlation is present, investigating
promoter binding (localization), expression levels, and enzymatic
activity/inhibition of the site-specific writer/eraser enzymes for
Table 4. Time-dependent correlation between mRNA expression and H3 modifications.
Gene Name Effects 10 mM PEITC treatment at four time points: 5, 8, 12, 18 h
Observation summary (significance compared with control)
STAT1 Relative mRNA H3K27me3 (%) Levels decreased in a time-dependent manner up to 12 h Levels increased in a time-dependent manner up to
12 h; correlate with mRNA expression (this data is shown as a representative histogram in Figure 5 in main text;
while remaining data presented in this table are shown as Figures S1, S2, S3, S4, S5)
NFkB1 Relative mRNA Suppression of mRNA only at 5 h; for 8 h onward, no significant suppression
H3K27me3 (%) With increase of mRNA levels 8h onward, H3K27me3 levels decreased and lost significance; correlates with
mRNA expression (Figure S1)
MMP7 Relative mRNA Levels decreased in a time-dependent manner up to 18 h
H3K27me3 (%) No correlation with mRNA levels except at 5 h. H3K27me3 and mRNA levels both decreased at later time
points (Figure S2)
H3Ac (%) Levels decreased in a time-dependent manner up to 18 h; correlate with mRNA expression (Figure S2)
CCL2 Relative mRNA Expression levels significantly low at all time points;
H3K27me3 (%) Correlation with mRNA unlikely (Figure S4)
CD40 Relative mRNA Expression levels significantly low at all time points;
H3K27me3 (%) Changes do not correlate with mRNA levels over time (Figure S3)
H3K9me2 (%) Changes do not correlate with mRNA levels over time (Figure S3)
IL8 Relative mRNA Suppression of mRNA only at 5 h; for 8 h onward, no significant suppression
H3K27me3 (%) With increase of mRNA levels, H3K27me3 level decreased, but remained significantly higher than control;
partial correlation with mRNA levels likely (Figure S5)
H3Ac (%) Acetylation levels remained low even after mRNA suppression was lost at later time points. No time-dependent
correlation with mRNA levels (Figure S5)
Effects: mRNA levels are normalized to GAPDH levels and quantified relative to positive control; ChIP values are determined as the percentage of input; *p,0.05 is
considered significant.
H3K27me3: trimethylation of histone H3 at lysine 27; H3K9me2: dimethylation of histone H3 at lysine 9; both marks were expected to have an inverse correlation with
mRNA expression; H3Ac: acetylation of histone H3; this mark was expected to have a direct correlation with mRNA expression; all six listed genes were tested for
changes in H3K27me3, H3k9me2, and H3-Ac changes in their promoter regions. Only statistically significant differential observations relative to positive control (LPS-
induced but not treated with PEITC) are noted in the table and discussed in the manuscript.
doi:10.1371/journal.pone.0064535.t004
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each of the reported GoI associated with PEITC exposure may
confirm or disconfirm the underlying molecular mechanisms
explaining the cause-and-effect relationship of the observed
changes. It is also possible that the effect of PEITC on the
epigenetic signature is cell-type dependent, which may explain
why, in an earlier report, PEITC functioned as a HDAC inhibitor
to activate the p21 gene in prostate cancer cells [53], while in our
observations, chromatin and gene expression changes associated
with PEITC exposure in colon cancer cells were repressive in
nature.
The absence of an observed correlation between RNA
expression and repressive histone modifications may also suggest
a number of possibilities that are worth investigating in future such
as: (i) demethylation of activation marks like H3K4me3 and
H3K36me3 (not investigated in the current work), which may
lower mRNA levels, (ii) cross talk with adjacent histone marks, i.e.,
combinatorial effects of multiple epigenetic marks including CpG
methylation, (iii) ability and/or inability of a ChIP antibody to
discriminate between a single histone mark when alone or in
combination with adjacent marks (e.g., H3K27me3 vs
H3K27me3S28ph), (iv) the role of micro-RNA in post-transcrip-
tional suppression of mRNA, which is independent of histone
modifications.
To summarize, PEITC down-regulated multiple genes repre-
senting key cellular functions related to the immune response and
cell proliferation in human colon cancer cells. These results
included the novel observation of suppression of MMP7 and other
genes by PEITC in SW480 cells. Cancer pathogenesis is complex
and often characterized by abnormalities in various checkpoints
and oncogenic pathways, and cancer cells have altered signaling
networks due to multiple alterations in gene expression. Overre-
liance on single-targeted interventions to treat or prevent disease
has impeded the drug discovery process over the past several
decades [3]. The robustness of biological systems to bypass
intervention at one checkpoint necessitates interventions that
target biomarkers representing multiple signaling pathways, which
also applies to potential dietary chemopreventive agents [54] such
as PEITC. Also, the discovery of novel biomarker(s) associated
with PEITC exposure and activity is critical for its clinical
development. Chemoprevention trials, with cancer incidence as
the primary endpoint, are expensive and time-consuming, as they
typically require thousands of human subjects, coordinated multi-
institutional efforts, and years of follow-up to draw meaningful
conclusions. Therefore, smaller cohort-specific pilot biomarker-
modulation studies could provide molecular endpoints and hence
rational justification for larger cancer prevention trials. We believe
that the information from this study contributes to the knowledge
base regarding the possible prognostic relevance of epigenetic
signatures in cancer cells and the likely prediction of therapeutic
responses based on these signatures. In addition, the role of
chromatin chemistry is now appreciated beyond clinical oncology
[6], such as in stress response [55], aging [56], behavior, and
addiction [57]. Chromatin and also chromatin-interacting proteins
have recently emerged as promising drug targets [58,59,60].
Therefore, the current work presents an encouraging case for the
chromatin context in diet–gene interaction studies, which can
potentially lead to new directions in ‘‘diet for human health’’
research beyond the field of cancer biology.
Supporting Information
Figure S1 Time-dependent effect of 10 mM PEITC
treatment on NFkB1 mRNA levels and on the
H3K27me3 methylation state. SW480 cells were treated with
10 mM PEITC at the indicated time points (A, B). NFkB1 mRNA
levels were normalized to GAPDH levels and expressed as a
percentage relative to positive-control cells (A). Histone H3
methylation changes at the NFkB1 promoter region in SW480
cells were determined using anti-H3K27me3 antibody for ChIP.
DNA sequences were quantified by real-time PCR (B). Data points
represent the mean 6 SEM (n= 4) from each experiment.
*p,0.05, **p,0.01, ***p,0.001 compared with positive-control
cells. The dotted green lines indicate a possible inverse correlation
between changes in mRNA levels and H3 modification status in
the cells.
(TIF)
Figure S2 Time-dependent effect of 10 mM PEITC
treatment on MMP7 mRNA levels, H3K27me3 methyla-
tion, and H3Ac acetylation states. (i) The MMP7 mRNA
levels were normalized to GAPDH levels and expressed as a
percentage relative to positive-control cells. (ii) Histone H3K27
trimethylation changes and (iii) Histone H3 acetylation changes at
the MMP7 promoter region in SW480 cells were determined
using anti-H3K27me3 and anti-H3Ac antibodies for ChIP. DNA
sequences were quantified by real-time PCR. Data points
represent the mean 6 SEM from each experiment. *p,0.05,
***p,0.001 compared with positive-control cells. The dotted
green lines indicate the presence of a correlation (negative/inverse
for methylation marks and positive/direct for acetylation marks)
while dotted red lines indicate the absence of such a correlation
between changes in mRNA levels and H3 modification states in
the cells.
(TIF)
Figure S3 Time-dependent effect of 10-mM PEITC
treatment on CD40 mRNA levels and on H3K27me3
and H3K9me2 methylation states. (i) The CD40 mRNA
levels were normalized to GAPDH levels and expressed as a
percentage relative to positive-control cells. (ii) Histone H3K27
trimethylation changes. (iii) Histone H3K9 dimethylation changes
at the CD40 promoter region in SW480 cells was determined
using anti-H3K27me3 and anti-H3K9me2 antibodies for ChIP.
DNA sequences were quantified by real-time PCR. Data points
represent the mean 6 SEM from each experiment. **p,0.01,
***p,0.001 compared with positive-control cells. The dotted red
lines indicate the absence of possible inverse correlations between
changes in mRNA levels and H3 modification status in the cells.
(TIF)
Figure S4 Time-dependent effect of 10-mM PEITC
treatment on CCL2 mRNA levels and on the
H3K27me3 methylation state. (i) The CCL2 mRNA levels
were normalized to GAPDH levels and expressed as a percentage
relative to positive-control cells. (ii) Histone H3K27 trimethylation
changes at the CCL2 promoter region in SW480 cells was
determined using anti-H3K27me3 antibody for ChIP. DNA
sequences were quantified by real-time PCR. Data points
represent the mean 6 SEM from each experiment. *p,0.05,
**p,0.01, ***p,0.001 compared with positive-control cells. The
dotted red lines indicate the absence of a possible inverse
correlation between changes in mRNA levels and H3 modification
status in the cells.
(TIF)
Figure S5 Time-dependent effect of 10-mM PEITC
treatment on IL8 mRNA levels and on H3K27me3
methylation and H3Ac acetylation states. (i) The IL8
mRNA levels were normalized to GAPDH levels and expressed as
a percentage relative to positive control cells. (ii) Histone H3K27
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trimethylation changes and (iii) Histone H3 acetylation changes at
the IL8 promoter region in SW480 cells were determined using
anti-H3K27me3 and anti-H3Ac antibodies for ChIP. DNA
sequences were quantified by real-time PCR. Data points
represent the mean 6 SEM from each experiment. *p,0.05,
**p,0.01, ***p,0.001 compared with positive-control cells. The
dotted green lines indicate the presence of an observed inverse
correlation while dotted red lines indicate the absence of a direct
correlation between changes in mRNA levels and H3 modification
states in the cells.
(TIF)
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